Unique ID issued by UMIN | UMIN000017810 |
---|---|
Receipt number | R000020635 |
Scientific Title | The study on the patients with idiopathic basal ganglia calcification (IBGC) in Japan |
Date of disclosure of the study information | 2015/06/08 |
Last modified on | 2019/11/12 17:31:52 |
The study on the patients with idiopathic basal ganglia calcification (IBGC) in Japan
The study on the patients with IBGC in Japan
The study on the patients with idiopathic basal ganglia calcification (IBGC) in Japan
The study on the patients with IBGC in Japan
Japan |
Idiopathic basal ganglia calcification (IBGC)
Neurology | Psychiatry |
Others
NO
To clarify the cases of IBGC in Japan, based on the funding of Ministry of Health, Labor and Welfare.
Others
To survey for cases of IBGC in Japanese population.
To search for headache in the patients with IBGC.
Others
Others
Not applicable
To lay the foundation for future researches of IBGC.
To clarify the headache in the patients with IBGC status quo in Japan.
Observational
Not applicable |
Not applicable |
Male and Female
Conspicuous calcification is observed in the basal ganglia and/or dentate nucleus on CT scanning image.
Calcification is bilateral and symmetrical.
Idiopathic (absence of biochemical abnormalities, and an infections, toxic, or traumatic cause).
To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.
500
1st name | Isao |
Middle name | |
Last name | Hozumi |
Gifu Pharmaceutical University
Laboratory of Medical Therapeutics and Molecular Therapeutics
501-1196
1-25-4 Daigaku-Nishi Gifu city, Gifu Prefecture, JAPAN 501-1196
058-230-8121
hozumi@gifu-pu.ac.jp
1st name | Isao |
Middle name | |
Last name | Hozumi |
Gifu Pharmaceutical University
Laboratory of Medical Therapeutics and Molecular Therapeutics
501-1196
1-25-4 Daigaku-Nishi Gifu city, Gifu Prefecture, JAPAN 501-1196
058-230-8121
hozumi@gifu-pu.ac.jp
Gifu Pharmaceutical University
Ministry of Health, Labor and Welfare
Japanese Governmental office
Japan
Japan Agency for Medical Research and Development
Ethics Committee of Gifu Pharmaceutical University
1-25-4 Daigakunishi Gifu, Gifu Prefecture, JAPAN
058-230-8100
syomuk@gifu-pu.ac.jp
NO
2015 | Year | 06 | Month | 08 | Day |
Unpublished
300
Open public recruiting
2014 | Year | 11 | Month | 12 | Day |
2014 | Year | 11 | Month | 12 | Day |
2014 | Year | 11 | Month | 12 | Day |
2024 | Year | 07 | Month | 31 | Day |
2024 | Year | 07 | Month | 31 | Day |
2024 | Year | 07 | Month | 31 | Day |
2024 | Year | 07 | Month | 31 | Day |
To lay the foundation for future researches of IBGC.
To clarify the headache in the patients with IBGC status quo in Japan.
2015 | Year | 06 | Month | 04 | Day |
2019 | Year | 11 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020635
Research Plan | |
---|---|
Registered date | File name |
2019/11/12 | 疫学研究計画書.docx |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |